Viking Global Opportunities Portfolio GP LLC (CIK 1629472) reported 5 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2025-10-09). Recent activity: Sell INBX (308,643 shares), Sell INBX (16,315 shares), Sell INBX (25,042 shares), Sell BBIO (3.5M shares), Sell BBIO (3.1M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-10-09 | Inhibrx Biosciences, Inc. (INBX) | Insider | Sell | 308,643 | $10.0M |
| 2025-10-09 | Inhibrx Biosciences, Inc. (INBX) | Insider | Sell | 16,315 | $526,159 |
| 2025-10-09 | Inhibrx Biosciences, Inc. (INBX) | Insider | Sell | 25,042 | $807,604 |
| 2025-07-01 | BridgeBio Pharma, Inc. (BBIO) | Insider | Sell | 3.5M | $154.0M |
| 2025-01-31 | BridgeBio Pharma, Inc. (BBIO) | Insider | Sell | 3.1M | $107.0M |
Source: SEC Form 4 filings · as of 2025-10-09